10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001493152-21-007259`
Period End Date	20201231
Filing Date	20210331
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	aim-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 39 Cash Flow Statement 81 Stockholders Equity 23

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.47M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$7.31M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$501.00K	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$1.09M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$776.00K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$44.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$34.00K	USD	Point-in-time
Preferred stock, shares designated	`PreferredStockSharesDesignated`	5.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$848.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$184.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$40.31M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.45M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.47M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$152.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$179.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$911.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.50M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.15M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.39M	shares	Point-in-time
Marketable securities, long term	`AvailableForSaleSecuritiesNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.15M	shares	Point-in-time
Marketable securities, long term	`AvailableForSaleSecuritiesNoncurrent`	$15.38M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.39M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$748.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.15M	shares	Point-in-time
Total assets	`Assets`	$64.58M	USD	Point-in-time
Total assets	`Assets`	$20.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$472.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$383.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$442.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$403.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$38.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$47.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$230.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$214.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.10M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.13M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$114.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$132.00K	USD	Point-in-time
Notes payable	`NotesPayableNoncurrent`	$3.91M	USD	Point-in-time
Notes payable	`NotesPayableNoncurrent`	-	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 19)	`LongTermDebtNoncurrent`	$1.88M	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 19)	`LongTermDebtNoncurrent`	$2.10M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$57.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$180.00K	USD	Point-in-time
Commitments and contingencies (Notes 9, 11, 12, 14, 15 and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 9, 11, 12, 14, 15 and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 732 shares designated, 778 shares issued and outstanding	`PreferredStockValue`	$778.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 732 shares designated, 778 shares issued and outstanding	`PreferredStockValue`	$732.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 42,154,371 and 10,386,754, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Common Stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 42,154,371 and 10,386,754, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$402.54M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$340.23M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-47.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-327.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-341.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$61.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.44M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.44M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.75M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$64.58M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$163.00K	USD	Annual
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$140.00K	USD	Annual
Production costs	`ManufacturingCosts`	$806.00K	USD	Annual
Production costs	`ManufacturingCosts`	$893.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.72M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.65M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.04M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$8.65M	USD	Annual
Impairment of other assets	`OtherAssetImpairmentCharges`	$135.00K	USD	Annual
Impairment of other assets	`OtherAssetImpairmentCharges`	-	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$15.31M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$12.58M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-12.44M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-15.15M	USD	Annual
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$89.00K	USD	Annual
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$219.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	$672.00K	USD	Annual
Interest expense and other finance costs	`InterestExpense`	$427.00K	USD	Annual
Settlement of litigation/Insurance Claim	`LitigationSettlementExpense`	$1.22M	USD	Annual
Settlement of litigation/Insurance Claim	`LitigationSettlementExpense`	-	USD	Annual
Extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$142.00K	USD	Annual
Extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-345.00K	USD	Annual
Fair value of convertible note adjustment	`ConvertibleNoteValuationAdjustment`	$-90.00K	USD	Annual
Fair value of convertible note adjustment	`ConvertibleNoteValuationAdjustment`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.51M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$123.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$1.19M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$905.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-9.40M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.40M	USD	Annual
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-47.00K	USD	Annual
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.45M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.40M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.40M	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-2.58	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.45	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.84M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.64M	shares	Annual

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-9.40M	USD	Annual
Net loss	`NetIncomeLoss`	$-14.40M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$665.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$735.00K	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-1.24M	USD	Annual
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$123.00K	USD	Annual
Abandonment of patents and trademarks	`ImpairmentOfIntangibleAssetsFinitelived`	$158.00K	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustments`	$-70.00K	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustments`	-	USD	Annual
Allowance for bad debt recovery	`AllowanceForLoanAndLeaseLossRecoveryOfBadDebts`	-	USD	Annual
Allowance for bad debt recovery	`AllowanceForLoanAndLeaseLossRecoveryOfBadDebts`	$30.00K	USD	Annual
Warrant modification	`WarrantModification`	$46.00K	USD	Annual
Warrant modification	`WarrantModification`	-	USD	Annual
Extinguishment of convertible note	`GainsLossesOnExtinguishmentOfDebt`	$142.00K	USD	Annual
Extinguishment of convertible note	`GainsLossesOnExtinguishmentOfDebt`	$-345.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$57.00K	USD	Annual
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$68.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$-27.00K	USD	Annual
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$37.00K	USD	Annual
Inventory write-off	`InventoryWriteDown`	-	USD	Annual
Inventory write-off	`InventoryWriteDown`	$1.09M	USD	Annual
Impairment of other assets	`OtherAssetImpairmentCharges`	$135.00K	USD	Annual
Impairment of other assets	`OtherAssetImpairmentCharges`	-	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$1.19M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$905.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$853.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$1.04M	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$288.00K	USD	Annual
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$112.00K	USD	Annual
Accounts receivables	`IncreaseDecreaseInAccountsReceivable`	$40.00K	USD	Annual
Accounts receivables	`IncreaseDecreaseInAccountsReceivable`	$191.00K	USD	Annual
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivableRelatedParties`	$83.00K	USD	Annual
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivableRelatedParties`	$-314.00K	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-671.00K	USD	Annual
Prepaid expenses and other current assets and other non current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-29.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$-27.00K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$37.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-207.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-89.00K	USD	Annual
Accrued interest expense	`IncreaseDecreaseInInterestPayableNet`	$231.00K	USD	Annual
Accrued interest expense	`IncreaseDecreaseInInterestPayableNet`	$129.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$39.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-731.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.07M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.37M	USD	Annual
Proceeds from sale of marketable securities	`PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm`	$-10.04M	USD	Annual
Proceeds from sale of marketable securities	`PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm`	-	USD	Annual
Purchase of short-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$18.61M	USD	Annual
Purchase of short-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.78M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$68.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$573.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$297.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.15M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.16M	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	$355.00K	USD	Annual
Financing obligation payments	`RepaymentsOfLongTermDebt`	$340.00K	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$3.63M	USD	Annual
Payoff of note payable	`RepaymentsOfNotesPayable`	$4.33M	USD	Annual
Payoff of note payable	`RepaymentsOfNotesPayable`	$2.21M	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$15.30M	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$61.25M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$56.56M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.39M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.03M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.17M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Point-in-time
Stock issued to settle accounts payable	`StockIssued1`	$15.00K	USD	Annual
Stock issued to settle accounts payable	`StockIssued1`	$129.00K	USD	Annual
Conversion of note payable in shares	`ConversionOfNotePayableIntoShares`	$1.24M	USD	Annual
Conversion of note payable in shares	`ConversionOfNotePayableIntoShares`	-	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$46.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$4.53M	USD	Annual
Operating lease - Right of Use Assets	`OperatingLeaseRightOfUseAssets`	$188.00K	USD	Annual
Operating lease - Right of Use Assets	`OperatingLeaseRightOfUseAssets`	$66.00K	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$5.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$61.29M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.44M	USD	Point-in-time
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$61.25M	USD	Annual
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$16.95M	USD	3 Qtrs
Shares issued for: Convertible note origination shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.47M	USD	3 Qtrs
Deemed dividends	`Dividends`	$135.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.04M	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$853.00K	USD	3 Qtrs
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.79M	USD	3 Qtrs
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$15.00K	USD	Annual
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$129.00K	USD	3 Qtrs
Series B preferred shares issued, net of offering costs	`PreferredSharesIssuedNetOfOfferingCosts`	$5.31M	USD	3 Qtrs
Series B preferred shares converted to common shares	`ConversionOfStockAmountConverted1`	$4.53M	USD	3 Qtrs
Series B preferred shares converted to common shares	`ConversionOfStockAmountConverted1`	$46.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-14.45M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.40M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.40M	USD	3 Qtrs
Balance	`StockholdersEquity`	$5.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$61.29M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.